Vimarsana
Biggest News Aggregation in the World

Page 2 - Checkmate Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Checkmate Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Checkmate Capital Today - Breaking & Trending Today

UPDATE - KT Corporation and Hanmi Pharmaceutical promote - Vimarsana News

UPDATE - KT Corporation and Hanmi Pharmaceutical promote

KT and Hanmi Pharmaceutical to jointly invest in Digital Pharm, a company specializing in digital therapeutics and electroceuticalsLeading the domestic...

Ignis Therapeutics Licenses NeuroSigma eTNS Technology for ADHD in a Significant China Licensing Transaction - Vimarsana News

Ignis Therapeutics Licenses NeuroSigma eTNS Technology for ADHD in a Significant China Licensing Transaction

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
Sh704m fake gold scam exposes Kenya's weak laws on dirty cash - Vimarsana News

Sh704m fake gold scam exposes Kenya's weak laws on dirty cash

Malaysian businessman has sued a host of law firms and banks involved in handling colossal sums in the scheme spanning from DR Congo, Hong Kong to Nai

NeuroSigma Announces a $5 Million Equity Investment by KT - Vimarsana News

NeuroSigma Announces a $5 Million Equity Investment by KT

Transaction follows the June 2021 announcement of a strategic digital health partnership between NeuroSigma and KTSignificant investment in NeuroSigma’s...

Elucid Raises $8M in Series A Funding - Vimarsana News

Elucid Raises $8M in Series A Funding

Elucid Raises $8M in Series A Funding Elucid, a Boston, MA-based medical technology company developing AI software to enable cardiovascular disease detection, raised $8M in Series A financing. The round was led by MedTex Ventures and Global Health Impact Fund. New and existing investors Checkmate Capital, IAG Capital, BlueStone Venture Partners, University of Michigan – Wolverine Venture Fund, Willamette Valley Capital LLC, and Angel Physicians Fund also participated in the round. The company intends to use the funds to to continue advancing its technology for non-invasive estimation of ca...